Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs| Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) | Delayed: 37.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.00 | 52 Week High | $34.07 | |||
| Open | $37.00 | 52 Week Low | $21.84 | |||
| Day High | $37.00 | P/E | N/A | |||
| Day Low | $37.00 | EPS | $0.00 | |||
| Volume | 26 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 803.48 -2.49 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $805.97 | 52 Week High | $592.36 | |||
| Open | $802.35 | 52 Week Low | $325.35 | |||
| Day High | $806.54 | P/E | 210.89 | |||
| Day Low | $792.57 | EPS | $3.81 | |||
| Volume | 425,596 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 36.77 +0.25 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.52 | 52 Week High | $66.55 | |||
| Open | $36.26 | 52 Week Low | $37.82 | |||
| Day High | $36.81 | P/E | N/A | |||
| Day Low | $36.09 | EPS | $0.00 | |||
| Volume | 2,332,449 | |||||
